IntelliCare app suite field trial

Eight weeks of IntelliCare apps plus light coaching produced large pre–post drops in depression and anxiety symptoms.

Keep what you just learned

Save these 11 cards to your NoteFren library. Your first review starts right away, and each card links back to the study it came from.

What was IntelliCare in this study?

An elemental, skills-based Android app suite for depression and anxiety.

What design was used?

Single-arm field trial with low-intensity coaching.

How many people enrolled?

105 consented and enrolled.

What entry criteria were used?

PHQ-9 ≥10 and/or GAD-7 ≥8 (score of 8 or higher).

How long did participants use the apps?

8 weeks with coaching support.

Did depression scores change?

Yes—significant PHQ-9 improvements across the sample.

Did anxiety scores change?

Yes—significant GAD-7 improvements across the sample.

What share reached depression remission (PHQ-9<5)?

37% (35/105) at end of treatment.

What share reached anxiety remission (GAD-7<5)?

42% (39/105).

What share met both depression and anxiety criteria at baseline?

60% (63/105).

What is a core design claim about IntelliCare?

It is elemental and eclectic—users combine small strategy apps rather than one theory-locked program.